PROVIDER TESTIMONIALS
What Providers Are Saying About RADIESSE
See why your peers value RADIESSE as an effective option for firmer, tighter skin for their patients.
Regeneration means something. It’s a biological term, isn’t it? Regeneration really means that using the body’s own processes, you have been able to rebuild the tissues to as close as possible to its original useful form. And I think, within aesthetics as well, that you also have to be able to see the results. So, regeneration truly is restoration of structure and function of the tissues.
A treatment patients can feel good about
Watch Dr. Kate Goldie explain why the patients at her practice rank RADIESSE at the top of the patient satisfaction lists.
“Over the years, the skin looks different. I can visually see that.”
Dr. Kate Goldie
Aesthetic Physician, United Kingdom
Dr. Katie Goldie is a paid consultant for Merz Aesthetics. Her statements are based on her professional expertise.
Hear From Patients
In a survey of 70 patients:
Regeneration through restoration
Watch Dr. Jani Van Loghem discuss how RAIDESSE can restore fibroblasts and the skin’s pathway to self-renewal through a non-inflammatory regenerative pathway.
“You can use its capacity to stimulate your patient’s tissue to start making ECM products.”
Dr. Jani Van Loghem
Aesthetics Physician, The Netherlands
Dr. Jani Van Loghem is a paid consultant for Merz Aesthetics. His statements are based on his professional expertise.
I’ve been using RADIESSE since 2005. You can use it as a filler, but it’s not just a filler. It’s a regenerative biostimulatory product because you can use its capacity to stimulate your patient’s tissue to start making ECM products like collagen, elastin, proteoglycans.
Jessica Manges is a paid consultant for Merz Aesthetics. Her statements are based on her professional expertise.
Business Impact
“Why I recommend RADIESSE in my practice is due to its ability to stimulate the body’s own collagen production, allowing me to deliver results that look natural, gradual, and regenerative rather than simply volumizing.
My patients appreciate not just the visible improvement, but the way their skin continues to improve over time.”
Jessica Manges
ARNP, Clearwater, FL
Explaining RADIESSE without the “F” word
Listen to an aesthetics key opinion leader discuss how they talk about RADIESSE as a regenerative biostimulator, not a “filler.”
Dr. David Funt
Plastic Surgeon, United States
Dr. David Funt is a paid consultant for Merz Aesthetics. His statements are based on his professional expertise.
What I do is I put the mirror on patients’ laps, have them look down, and all of a sudden they appreciate the areas of laxity where tone has been lost in their skin. So, that is another indication where I say, “hey, I can do something for them that’s using the regenerative qualities of RADIESSE.” And when I start to explain what this product does is it awakens those cells to make that collagen and the elastin and improve the number of blood vessels that are there and even improve the quality of the top layer of your skin, the epidermis.
PRACTICE RESOURCES
Discover RADIESSE Resources for Providers
From customizable promotional resources to self-enrolling training opportunities, explore tools your staff can use to integrate RADIESSE into
your practice.
BECOME A RADIESSE PROVIDER
Ready to Re-Awaken Your Patients’ Skin From Within?
Actual patients. Individual results may vary.
Indication:
RADIESSE® and RADIESSE® (+) Injectable Implants are FDA-approved for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. RADIESSE® is also indicated for hand augmentation to correct volume loss in the dorsum of the hands. Radiesse® (+) injectable implant is also indicated for deep injection (subdermal and/or supraperiosteal) for soft tissue augmentation to improve moderate to severe loss of jawline contour in adults over the age of 21.
RADIESSE® and RADIESSE® (+) Important Safety Information:
Contraindications:
These products are contraindicated for patients with severe allergies manifested by a history of anaphylaxis, or history or presence of multiple severe allergies; patients with known hypersensitivity to any of the components; and patients with bleeding disorders. RADIESSE® (+) is contraindicated in patients with known hypersensitivity to lidocaine or anesthetics of the amide type.
Warnings:
Introduction of the product into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take extra care when injecting soft tissue fillers, for example inject the product slowly and apply the least amount of pressure necessary. Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, and damage to underlying facial structures. Immediately stop the injection if a patient exhibits any of the following symptoms, including changes in vision, signs of a stroke, blanching of the skin, or unusual pain during or shortly after the procedure. The treating physician should be knowledgeable regarding any pretreatment evaluation and appropriate interventions in the event of intravascular disseminated injection. Prompt intervention by an appropriate medical specialist should be given should these signs or symptoms of intravascular injection occur.
Use of these products in any person with active skin inflammation or infection in or near the treatment should be deferred until the inflammatory or infectious process is controlled.
Do not overcorrect (overfill) a contour deficiency with these products.
Injection into the dorsum of the hand may cause adverse events that last for more than 14 days, and may result in temporary difficulty performing activities (48% of study patients reported this adverse event). RADIESSE® may cause nodules, bumps or lumps in the dorsum of the hand (12% reported this event) and can last up to 1 year.
The safety and effectiveness for use in the lips has not been established. There have been published reports of nodules associated with the use of these products injected into the lips.
Precautions:
In order to minimize the risk of potential complications, this product should only be used by healthcare practitioners who have appropriate training, experience and who are knowledgeable about the anatomy at and around the injection site. Healthcare practitioners should fully familiarize themselves with the product, the product educational materials and the entire package insert.
The safety and effectiveness of RADIESSE® or RADIESSE® (+) in the following situations has not been established:
- Beyond 3 years in the face and 1 year in the hand
- In the periorbital area
- Interactions between RADIESSE® or RADIESSE® (+) and drugs or other substances or implants
- Use during pregnancy, or in breastfeeding women
- In the face in patients under 18 years of age
- In the dorsum of the hand in patients under 26 years old and over 79 years old
- In patients with increased susceptibility to keloid formation and hypertrophic scarring
- With concomitant dermal therapies such as epilation, UV irradiation, or laser, mechanical, or chemical peeling procedures
These products contain calcium hydroxylapatite (CaHA) particles that are radiopaque and are clearly visible on CT Scans and may be visible in standard, plain radiography.
As with all transcutaneous procedures, injection of these products carries a risk of infection. Injection in the jawline may temporarily alter jaw function.
Use of RADIESSE® in the dorsum of the hand may result in significant swelling of the dorsum of the hand.
To help avoid needle breakage, do not attempt to straighten a bent needle or cannula. Discard it and complete the procedure with a replacement needle.
Patients who are using medications that can prolong bleeding, such as aspirin or warfarin, may experience increased bruising or bleeding at the injection site.
Patients with a history of previous herpetic eruption may experience reactivation of the herpes.
Patients should minimize strenuous activity and exposure of the treated area to extensive sun or heat exposure for approximately 24 hours after treatment or until any initial swelling and redness has resolved.
Adverse Events:
Common adverse events observed in clinical studies of RADIESSE® or RADIESSE® (+) include bruising, redness, swelling, pain, itching, lumps/bumps at site of injection, difficulty chewing and other local side effects.
Cases of delayed-onset inflammation have been reported to occur at the dermal filler treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inflammation was responsive to treatment or resolved on its own.
Information on adverse events from post-market surveillance of RADIESSE® and RADIESSE® (+) are included in the Instructions for Use (IFU) and Patient Information Guide (PIG) based on an assessment of seriousness and potential causal relationship to RADIESSE® or RADIESSE® (+). Please see the IFU and PIG available at www.radiesse.com for a complete list of these events.
To report a problem with RADIESSE® or RADIESSE® (+), please call MyMerz Solutions at 1-844-469-6379.
For complete Safety Information please refer to the Instructions for Use at Radiesse.com.
Rx only
Reference: 1. Moers-Carpi M, et al. Dermatol Surg. 2007;33(suppl 2):S144-S151.